Arvinas Inc (ARVN)
32.66
+0.55
(+1.71%)
USD |
NASDAQ |
May 17, 16:00
31.01
-1.65
(-5.05%)
After-Hours: 20:00
Arvinas Cash from Investing (TTM): -62.90M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -62.90M |
| December 31, 2023 | 203.50M |
| September 30, 2023 | 276.60M |
| June 30, 2023 | 312.40M |
| March 31, 2023 | 372.80M |
| December 31, 2022 | 242.80M |
| September 30, 2022 | 107.80M |
| June 30, 2022 | -739.10M |
| March 31, 2022 | -1.097B |
| December 31, 2021 | -1.314B |
| September 30, 2021 | -1.141B |
| Date | Value |
|---|---|
| June 30, 2021 | -340.70M |
| March 31, 2021 | -85.99M |
| December 31, 2020 | 164.30M |
| September 30, 2020 | 11.96M |
| June 30, 2020 | -79.14M |
| March 31, 2020 | -88.98M |
| December 31, 2019 | -93.10M |
| September 30, 2019 | -99.53M |
| June 30, 2019 | -55.92M |
| March 31, 2019 | -96.95M |
| December 31, 2018 | -179.67M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.314B
Minimum
Dec 2021
372.80M
Maximum
Mar 2023
-175.25M
Average
-71.02M
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc | -33.86B |
| Johnson & Johnson | -2.901B |
| Bristol-Myers Squibb Co | -21.70B |
| Janux Therapeutics Inc | -146.19M |
| ACADIA Pharmaceuticals Inc | -174.56M |